[Utility of B-type natriuretic peptide measurement in outpatients with heart failure with preserved ejection fraction]

What Was Tested

This observational study paper looks at BNP (Nesiritide).

The aim of this study was to identify the BNP cutoff for a diagnosis of HFPEF in outpatients.

Why It Was Studied

Heart failure with preserved ejection fraction (HFPEF) is a highly prevalent syndrome that is difficult to diagnose in outpatients.

The measurement of B-type natriuretic peptide (BNP) may be useful in the diagnosis of HFPEF, but with a different cutoff from that used in the emergency room.

Who Took Part

By PubMed's age tags, the people studied were older adults, both men and women.

What Was Measured

The measurement of B-type natriuretic peptide (BNP) may be useful in the diagnosis of HFPEF, but with a different cutoff from that used in the emergency room.

Topics PubMed links to this paper include Cross-Sectional Studies, Heart Failure, Natriuretic Peptide, Brain, Outpatients, Reproducibility of Results and Stroke Volume.

Author keywords: B-type natriuretic peptide, Diastole, Diástole, Doentes ambulatórios, Insuficiência cardíaca and Peptídeo natriurético tipo B.

What This Means in Plain Language

This is a observational study of BNP (Nesiritide).

The abstract goes on to report its results in about 7 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 2013 (Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology), a journal based in Portugal.

More context: the BNP (Nesiritide) compound page, all human trials.